"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

copy info icon

Key data

Status

Active

KRS number

0000130826copy info icon

REGON

01576517100000copy info icon

NIP/VAT code

5222734952copy info icon

VAT registration date

01/08/2004

VAT status

Active

Bankruptcy proceedings

No proceedings

"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

Registered address

UL. KRAKOWIAKÓW 46, 02-255, WARSZAWA, POLSKAcopy info icon
See on map
Website

Website

-
A Pie Chart

A

Highest
Highest reliabilityLowest reliability

Reliability

Selected TriangleA - Highest
B - High
C - Average
D - Low
E - Lowest

Incorporation date

12/09/2002

Share capital

6,050,000.00 PLN

Primary activity

Wholesale of pharmaceutical goods

Representatives

5

Representatives rights

DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM;

Representatives

dot
Member of the management boardA****** P**** P********
dot
Member of the management boardL*** B* S****
dot
Member of the management boardM****** R*******-H***

Business linkages

Price: €14.99 (without VAT)
Premium users: 1.00 credit

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit

People

Representatives

5
Personsort default icon
Titlesort default icon
A****** P**** P********
Member of the management board
L*** B* S****
Member of the management board
M****** R*******-H***
Member of the management board
T**** H*****
Member of the management board
Andrzej Paweł Popkowski
Member of the management board

Persons with Significant Control

1
psc login icon

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

€

Net Profit (zł)

18,141,905

Net Profit (zł)

18,141,905

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit
Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%)info
Liquidity ratioinfo
Net profitability (%)info
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)
2022
683,972,067
7,360,943
5,615,539
0.06
1.16
0.82
42,187,231
240,290,478
0
0
2023
1,029,815,733
21,342,107
16,155,773
0.05
1.15
1.57
58,343,004
382,144,441
0
0
2024
1,223,832,935
22,584,898
18,141,905
0.06
1.14
1.48
76,484,908
538,803,561
0
-
2024
1,223,832,935
22,584,898
18,141,905
0.06
1.14
1.48
76,484,908
538,803,561
0
-

2024

Turnover (zł)

1,223,832,935 złAscended19 % *

Profit before tax (zł)

22,584,898 złAscended6 % *

Net Profit (zł)

18,141,905 złAscended12 % *

Working capital requirement (%)

0.06 Ascended20.00 % *

Liquidity ratio

1.14 Descended-0.87 % *

Net profitability (%)

1.48 %Descended-5.73 % *

Equity (zł)

76,484,908 złAscended31 % *

Current liabilities (zł)

538,803,561 złAscended41 % *

Non current liabilities (zł)

0 złAscended- *

Non-current Assets (zł)

-
*over the last year starting selected period

Credit history

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

Credit report

Price: 1.00 credit
Unpaid debts
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Debt typesort default icon
-
-
-
-
Debt payment history
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Payment datesort default icon
Debt typesort default icon
-
-
-
-
-

Documents

"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

23
Datesort default icon
Descriptionsort default icon
12/06/2025
OD 01.01.2024 DO 31.12.2024
01/07/2024
OD 01.01.2023 DO 31.12.2023
06/06/2023
OD 01.01.2022 DO 31.12.2022
31/08/2022
OD 01.01.2021 DO 31.12.2021
01/07/2021
OD 01.01.2020 DO 31.12.2020